Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

W. Zeijlemaker, A. Kelder, Y. J. M. Oussoren-Brockhoff, W. Scholten, A. N. Snel, D. Veldhuizen, J. Cloos, G. J. Ossenkoppele, G. J. Schuurhuis

Research output: Contribution to journalArticleAcademicpeer-review

64 Citations (Scopus)
Original languageEnglish
Pages (from-to)708-715
JournalLeukemia
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 2016

Cite this